John Lazo Email
Chief Scientific Officer . KeViRx
Charlottesville, VA
LocationPrimary Email
How to contact John Lazo
Join and see John's contact info for free!Current Roles
Employees:
6Revenue:
$930kAbout
KeViRx, Inc. is a preclinical stage pharmaceutical company headquartered in Charlottesville, VA. We are developing small molecules drugs that treat microvascular leakage and inflammation, pathologies that are the basis for many diseases, including cancer and respiratory disease. We are now entering IND-enabling studies for pulmonary microvascular leakage and inflammation during acute lung injury. \n\nOur lead asset, KVX-053 has potent anti-inflammatory and immunomodulatory effects. In preclinical models, KVX-053 reduces lung injury scoring & the biomarkers of lung injury, inflammation & proinflammatory cytokine release, & immune cell infiltration into the lung. KVX-053 also improves lung function after lung injury.\n\nContact us for more information at [email protected].KeViRx Address
Charlottesville, VA
United States